...
首页> 外文期刊>Thoracic cancer. >miR-21-5p/SMAD7 axis promotes the progress of lung cancer
【24h】

miR-21-5p/SMAD7 axis promotes the progress of lung cancer

机译:miR-21-5p / smad7轴促进肺癌的进展

获取原文

摘要

Background Lung cancer is one of the most common malignant tumors threatening human health. The aim of this study was to investigate the function of miR-21-5p in lung cancer progression. Methods We analyzed the expression levels of miR-21-5p in lung cancer tissues and cell lines. The qRT-PCR and MTT assays were performed after transfection with miR-21-5p mimic, inhibitor and negative control into lung cancer cells. Results Luciferase reporter assays showed miR-21-5p directly target SMAD7. The miR-21-5p inhibitor significantly suppressed lung cancer cell proliferation, invasion and migration. We found that SMAD7 was upregulated in lung cancer tissue. In addition, we found that SMAD7 inhibited lung cancer cell proliferation and miR-21-5p mimic damaged the inhibitory effect of SMAD7. Conclusions miRNA-21-5p may promote cell proliferation, migration and invasion by spoiling SMAD7 expression in lung cancer cells.
机译:背景技术肺癌是威胁人类健康的最常见的恶性肿瘤之一。 本研究的目的是探讨miR-21-5p在肺癌进展中的功能。 方法,我们分析了肺癌组织和细胞系中miR-21-5p的表达水平。 在用MiR-21-5P模拟,抑制剂和阴性对照转染后进行QRT-PCR和MTT测定,进入肺癌细胞。 结果荧光素酶报告器测定显示MIR-21-5P直接靶向SMAD7。 miR-21-5p抑制剂显着抑制肺癌细胞增殖,侵袭和迁移。 我们发现SMAD7在肺癌组织中上调。 此外,我们发现Smad7抑制肺癌细胞增殖和MiR-21-5P模仿损坏了Smad7的抑制作用。 结论MiRNA-21-5P可以通过破坏肺癌细胞中的Smad7表达来促进细胞增殖,迁移和侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号